Characterisation of yeasts implicated in vulvovaginal candidosis in Irish women

British Journal of Biomedical Science

Volumn 56, Issue 2, 1999, Pages 99-104

  Al Rawi, Nada ^a   Kavanagh, Kevin ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Candida albicans; Candidiasis, vulvovaginal; Virulence

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CLOTRIMAZOLE; NYSTATIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA LUSITANIAE; CANDIDA TROPICALIS; CELL ADHESION; CHEEK MUCOSA; ENZYME SYNTHESIS; EXTRACELLULAR SPACE; FEMALE; FEMALE GENITAL TRACT INFECTION; FUNGUS IDENTIFICATION; HUMAN; HUMAN CELL; IRELAND; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; VAGINA CANDIDIASIS; VAGINA CYTOLOGY; VAGINITIS;

ADOLESCENT; ADULT; CANDIDA; CANDIDIASIS, VULVOVAGINAL; CELL ADHESION; FEMALE; HUMANS; MICROBIAL SENSITIVITY TESTS; VIRULENCE;

EID: 0032790727     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Hurley R, De Louvois J. Candida vaginitis. Postgrad Med J 1979; 55:645-7.
2. O'Connor MI, Sobel JD. Epidemiology of recurrent vulvovaginal candidiasis: identification and strain differentiation of Candida aibicans. J Infect Dis 1986; 154:358-62.
3. Odds F. Candida and candidosis, 2nd edn. London: Bailliere Tindall, 1988.
4. Sobel JD. Vaginitis. N Engl J Med 1997; 337:1896-903.
5. Reed BD. Risk factors for Candida vulvovaginitis. Obstet Gynecol Surg 1992; 47:55-60.
6. Sobel JD, Myers PG, Kaye D, Levison ME. Adherence of Candida albicans to human vaginal and buccal epithelial cells. J Clin Microbiol 1981; 143:76-82.
7. Segal E, Soroka A, Schechter A. Correlative relationship between adherence of Candida albicans to human vaginal epithelial cells in vitro and Candida vaginitis. J Med Vet Mycol 1984; 22:191-200.
8. Ruchel R. Properties of a purified proteinase from the yeast Candida aibicans. Biochim Boiphys Acta 1981; 659:99-113.
9. Sobel JD. Controversial aspects in the management of vulvovaginal candidosis. J Am Acad Dermatol 1994; 31:S10-13.
10. Spinillo A, Nicolla S, Colonna L, Marangoni E, Cavanna C, Michelone G. Frequency and significance of drug resistance in vulvovaginal candidiasis. Gynecol Obstet Invest 1994; 38:130-3.
11. Redondo-Lopez V, Lynch M, Schmitt C, Cook R, Sobel JD. Torulupsis glabrata vaginitis: clinical aspects and susceptibility to antifungal agents. Obstet Gynecol 1990; 76:651-5.
12. Odds FC, Bernaerts R. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol 1994; 32:1923-9.
13. Kimura LH, Pearsall NN. Adherence of Candida albicans to human epithelial cells. Infect Immun 1978; 21:64-8.
14. Price MF, Wilkinson ID, Gentry LO. Plate detection method for detection of phospholipase activity in Candida albicans. Sabouradia 1982; 20:7-14.
15. Staib F. Serum-proteins as nitrogen source for yeast-like fungi. Sabouradia 1965; 4:187-93.
16. Barren-Bee K, Hayes Y, Wilson RG, Ryley JF. A comparison of phospholipase activity, cellular adherence and pathogenicity of yeasts. J Gen Microbiol 1985; 131:1217-21.
17. Perera J, Clayton Y. Incidence, species distribution and antifungal sensitivity pattern of vaginal yeasts in Sri Lankan women. Mycoses 1994; 37:357-60.
18. Ibrahaim AS, Mirbod F, Filler SG et al. Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect Immun 1995; 63:1993-8.
19. Denning DW, Baily GG, Hood SV. Azole resistance in Candida. Eur J Clin Microbiol Infect Dis 1997; 16:261-80.